Retraction notice to " HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells" [eBioMedicine 48 (2019) 117 - 129]

Affiliations

¹ Tianjin Life Science Research Center, Tianjin Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, Basic Medical School, Tianjin Medical University, Tianjin 300070, China.
² The Cancer Institute, Tangshan People's Hospital, Tangshan 063001, China.
³ State Key Laboratory of Oncology in Southern China, Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, China.

Lili Yao et al. EBioMedicine. 2021 Oct.

. 2021 Oct:72:103667.

doi: 10.1016/j.ebiom.2021.103667.

¹ Tianjin Life Science Research Center, Tianjin Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, Basic Medical School, Tianjin Medical University, Tianjin 300070, China.
² The Cancer Institute, Tangshan People's Hospital, Tangshan 063001, China.
³ State Key Laboratory of Oncology in Southern China, Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, China.

No abstract available

Retraction of

RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells.
Yao L, Zhou Y, Sui Z, Zhang Y, Liu Y, Xie H, Gao H, Fan H, Zhang Y, Liu M, Li S, Tang H. Yao L, et al. EBioMedicine. 2019 Oct;48:117-129. doi: 10.1016/j.ebiom.2019.09.012. Epub 2019 Sep 14. EBioMedicine. 2019. Retraction in: EBioMedicine. 2021 Oct;72:103667. doi: 10.1016/j.ebiom.2021.103667. PMID: 31530503 Free PMC article. Retracted.